No items found.
Synergy Rx offers one of the broadest medication menus in the GLP-1 telehealth space, with seven product options spanning compounded and FDA-approved brand-name medications in both injectable and oral formats. Compounded semaglutide starts at $199/month, compounded tirzepatide at $349/month, and brand-name options include Ozempic ($499), Wegovy ($947), and Mounjaro ($947). The platform claims LegitScript certification and was not on the FDA's September 2025 warning letter list. However, SynergyRx has no Trustpilot presence and shares identical infrastructure with BreezeMeds — same medical team, website template, and marketing claims — suggesting they are operated by the same entity.
The medication range is the clear standout: seven options including compounded semaglutide and tirzepatide in both injectable and oral dissolving tablet formats, plus brand-name Wegovy, Mounjaro, and Ozempic. This gives providers maximum flexibility in treatment selection. The platform also expands beyond weight loss into hair, sexual health, skin, and wellness categories. A $100 welcome credit is currently offered, and HSA/FSA payments are accepted. The LegitScript certification seal, if verified, is a meaningful trust signal.
The pricing structure is less transparent than some competitors, with promotional pricing that may vary and brand-name options adding significant cost. The platform is relatively newer in the space, which means fewer long-term patient reviews are available compared to established competitors. Patients interested in FDA-approved options should verify current availability and pricing directly.
Synergy Rx is a strong choice for patients who value medication flexibility and want the option to access FDA-approved brand-name GLP-1 drugs alongside more affordable compounded alternatives. The broader formulary gives clinicians more room to personalize treatment, making it well-suited for patients with specific medication preferences or those who may want to transition between compounded and branded options over time.
Synergy Rx offers a comprehensive range of GLP-1 medications including compounded semaglutide (injectable and oral tablet), compounded tirzepatide (injectable and oral tablet), and FDA-approved brand-name options like Wegovy, Zepbound, and Ozempic when medically appropriate. This breadth of options is wider than most telehealth competitors.
Compounded medication programs start at approximately $200/month with promotional pricing available. FDA-approved brand-name medications are priced separately and typically cost more. All programs include provider consultations, personalized treatment plans, and ongoing medical support.
Yes. Synergy Rx offers oral dissolving tablet formulations of both semaglutide and tirzepatide for patients who prefer a needle-free option. These are compounded formulations prescribed after a clinical evaluation and delivered to your home.
Patients complete an online health intake form covering medical history, current medications, and weight loss goals. A licensed provider reviews the information and determines eligibility. If approved, a personalized treatment plan is created and medication is shipped to your home with ongoing provider oversight available.
SynergyRx does not require a subscription or long-term contract. Contact your provider through the patient portal if you wish to stop treatment. Review the refund policy for orders already placed.
